NEPI Rockcastle N.V. is a public limited company domiciled in the Netherlands, with registration number at the Dutch Chamber of Commerce 87488329. The Company's shares are listed on the Main Board of the JSE Limited, Euronext Amsterdam and A2X. NEPI Rockcastle is the premier owner and operator of shopping centres in Central and Eastern Europe. The Group benefits from a highly-skilled internal management team which combines asset management, development, investment, leasing and financial expertise. NEPI Rockcastle N.V. registered office at Strawinskylaan 563, WTC Zuidas, Tower Ten, 5th Floor, 1077 XX Amsterdam. Rockcastle N.V. was established in 2007 and was incorporated in Netherlands.
Research context
Acceleron Pharma Inc appears in PyInvesting’s Frankfurt Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- EUR
- Sector
- Real Estate
- Industry
- Real Estate - Diversified
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
5 years, 6 months ago
Acceleron Pharma Inc is currently in a long term downtrend where the price is trading 2.7% below its 200 day moving average.
From a valuation standpoint, the stock is 93.7% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 82.1.
Acceleron Pharma Inc's total revenue sank by 34.2% to $26M since the same quarter in the previous year.
Its net income has dropped by 143.5% to $-57M since the same quarter in the previous year.
Finally, its free cash flow fell by 124.7% to $-39M since the same quarter in the previous year.
Based on the above factors, Acceleron Pharma Inc gets an overall score of 1/5.